Pharma & Medical Devices
29.3K views | +1 today
Follow
 
Scooped by Richard Meyer
onto Pharma & Medical Devices
Scoop.it!

Top 10 Pharma Advertising Budgets - 2012

Top 10 Pharma Advertising Budgets - 2012 | Pharma & Medical Devices | Scoop.it
While DTC advertising spending has backed off from the $5-billion-a-year highs set during the boom years of the last decade, significant sums are still spent, particularly by the top 10 spenders.
Richard Meyer's insight:

Direct-to-consumer (DTC) advertising, something that once seemed shocking, has become such a part of the television landscape that it raises few eyebrows any longer. Oh, there was an FDA study and finding last year that calming voice-overs and images of puppies and beach houses did not distract consumers from picking up on the health risks of the products being pitched. And a recent study found that voluntary industry guidelines have been ignored to the point that family-hour viewing often comes with a dose of erectile dysfunction drug advertising. But all in all, it is a part of doing business embraced by consumers and used by drugmakers of all ilk.


more...
No comment yet.
Pharma & Medical Devices
Latest news on patients, healthcare and medical devices from around the Web
Curated by Richard Meyer
Your new post is loading...
Your new post is loading...
Scooped by Richard Meyer
Scoop.it!

"Fake news" and its impact on health care communications

"Fake news" and its impact on health care communications | Pharma & Medical Devices | Scoop.it
"Fake news" is front and center in the national debate, but its impact on health care communications is underestimated. Health care professionals (HCPs) have always relied on third-party endorsers from important media outlets to educate the public on health issues. If traditional influencers lose their credibility, how can disease-awareness campaigns have the weight they need to drive change?
The established media is an important ally to industry in educating consumers (and even HCPs), driving disease awareness and announcing new treatments. These efforts contribute to better health, increased early detection and greater discussion about treatment options that match patients' personal needs.
But with many Americans now skeptical of journalists and medical experts, who will lead the battle for better health? The most distrustful communities also tend to be the ones with the worst health stats, such as high incidence of cardiovascular disease, addiction and suicide.
The potential harm that unfiltered and biased health information can have is alarming. We already have seen its impact in areas like children's vaccines.
What is the future of the health care communications industry, which is fact- and data-driven, in a world where facts don't seem to matter anymore?
--Laura Schoen, president, Global Practice Group, Weber Shandwick-IPG and member of the Executive Committee of the Coalition for Healthcare Communication
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion) -- The Motley Fool

The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion) --  The Motley Fool | Pharma & Medical Devices | Scoop.it
These prescription drugs raked in billions of dollars last year. But several of them might not be so lucrative for much longer.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Naperville pharma exec wants industry focus on lives saved

Naperville pharma exec wants industry focus on lives saved | Pharma & Medical Devices | Scoop.it
CHICAGO — Jim Robinson just wrapped up his first year as president of Astellas Americas, and it was quite a year for the pharmaceutical industry.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Prescribed Painkillers Didn’t Cause the Opioid Crisis

Prescribed Painkillers Didn’t Cause the Opioid Crisis | Pharma & Medical Devices | Scoop.it
People who need pain meds aren't usually the ones who get addicted.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Obesity now kills more people worldwide than car crashes, terror attacks, and Alzheimer's combined

Obesity now kills more people worldwide than car crashes, terror attacks, and Alzheimer's combined | Pharma & Medical Devices | Scoop.it
Five takeaways from a giant study on an epidemic governments can’t ignore.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Drug industry braces for an attack on TV ads, even "Gut Guy"

Drug industry braces for an attack on TV ads, even "Gut Guy" | Pharma & Medical Devices | Scoop.it
The drug industry is worried that Congress may seek to eliminate its tax break for advertising costs, which would amount to a $50 billion hit over a decade.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

JAMA study: technology to self-monitor blood glucose levels no better than traditional management of type 2 diabetes

JAMA study: technology to self-monitor blood glucose levels no better than traditional management of type 2 diabetes | Pharma & Medical Devices | Scoop.it
Diabetes management is among the most active, well-funded and rapidly-evolving areas of digital health. Connected tools that allow people living with diabetes to monitor their own blood glucose levels and work with digital coaching platforms to choose the best lifestyle practices to stay healthy abound, as do analytics platforms that enable remote monitoring and more detail-rich data visualization to help clinicians keep better tabs on their patients.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Pharma Websites and “Professionals-Only” Information: The Implications for Patient Trust and Autonomy

Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Patient Satisfaction Becomes Critical Concern for Hospitals

Patient Satisfaction Becomes Critical Concern for Hospitals | Pharma & Medical Devices | Scoop.it
A recent survey from Vocera shows the growing importance of patient satisfaction and gives an extensive overview of how experience shapes hospitals.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Pharma: Leadership is the most decisive factor for a digital program’s success or failure.

Pharma: Leadership is the most decisive factor for a digital program’s success or failure. | Pharma & Medical Devices | Scoop.it
According to McKinsey Global Survey results executives most often attribute the success of digital programs to managerial factors—senior management’s interest and attention, internal leadership, go…
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

The complex and evolving DTC advertising landscape

The complex and evolving DTC advertising landscape | Pharma & Medical Devices | Scoop.it
It's no secret that the American Medical Association isn't a huge fan of direct-to-consumer (DTC) pharmaceutical advertising. But that hasn’t stopped pharma marketers from continuing to invest in promoting their brands. Indeed, pharma is currently the 7th largest ad category in the U.S. as ranked by total spending which reached $6.4 billion last year – a growth of 64% since 2012.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

mHealth Apps for Cancer Survivors Aren’t Meeting Their Needs

mHealth Apps for Cancer Survivors Aren’t Meeting Their Needs | Pharma & Medical Devices | Scoop.it
Study finds mHealth apps for cancer survivors aren't doing the job
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

A Drug Maker Spends Big in Washington to Make Itself Heard

A Drug Maker Spends Big in Washington to Make Itself Heard | Pharma & Medical Devices | Scoop.it
Mallinckrodt’s spending on political donations and lobbying comes as the drug industry as a whole beefs up its Capitol Hill presence.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Judging the benefits and harms of medicines

Only trustworthy evidence will earn the public’s trust

How should society judge the safety and efficacy of drugs? This was the question posed by England’s chief medical officer, Sally Davies, in February 2015. Citing controversies about oseltamivir (Tamiflu) and statins, as well as growing disquiet about overmedication by doctors and conflicts of interest among researchers, she feared an erosion of public trust and asked the Academy of Medical Sciences to undertake a review.1 In June that same year, editorialists in The BMJ called on the academy to recommend “simple practical improvements that would address legitimate concerns.”2 The academy has now published its report.3 Does it deliver?

From the outset of the review, the academy confirmed that there is a problem. Its survey found that only one in three members of the public trusts the results of research. It also found that more than four fifths of general practitioners and two thirds of British adults disbelieved the results of trials funded by the drug industry.

In response to this finding, which the chair of the report, John Tooke, called “startling,”4 the academy has produced a wide ranging report that says many of the right things. But the overall result is disappointing. In their 2015 editorial, Heneghan and Goldacre warned against focusing on gaining the public’s trust through false assurances.2 They proposed instead improving the evidence base through changes in the funding, conduct, and dissemination of research. The academy report includes welcome calls for researchers to involve patients and be more transparent, but its main focus (taking up half …
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis

Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Why cancer patients don't have enough information to make decisions about their treatments

Why cancer patients don't have enough information to make decisions about their treatments | Pharma & Medical Devices | Scoop.it
At a time when expensive new cancer treatments are proliferating rapidly, patients have more therapy choices than ever before. Yet they are largely kept in the dark because their doctors either can’t or won’t communicate clearly. Many patients compound the problem by avoiding news they don’t want to hear.
more...
Janifar's comment, June 25, 6:37 AM
nice
Pharma Guy's curator insight, June 27, 7:44 AM

Doctors also may not have enough information about oncology drugs: http://sco.lt/95IUzZ

Scooped by Richard Meyer
Scoop.it!

Health Effects of Overweight and Obesity in 195 Countries over 25 Years — NEJM

Health Effects of Overweight and Obesity in 195 Countries over 25 Years — NEJM | Pharma & Medical Devices | Scoop.it
Original Article from The New England Journal of Medicine — Health Effects of Overweight and Obesity in 195 Countries over 25 Years
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Drugmakers hike prices regardless of rebates, says PCMA

Drugmakers hike prices regardless of rebates, says PCMA | Pharma & Medical Devices | Scoop.it
Drugmakers' pricing strategies are not connected to the rebates and discounts they negotiate with pharmacy benefit managers, according to a new analysis from the Pharmaceutical Care Management Association. The study found that prices rise even when rebates are low, or non-existent. Some high-priced drugs like Sovaldi, a hepatitis C drug which initially cost $84,000, involved no rebates at all until other competitors came to market.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Roche combo of breast cancer drugs shows modest benefit

Roche combo of breast cancer drugs shows modest benefit | Pharma & Medical Devices | Scoop.it
A clinical trial from Roche Holding AG combining the company's newer targeted drug for breast cancer with an older treatment resulted in a modest benefit for women with a specific type of disease, according to data presented on Monday.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Health Care Providers Must Stop Wasting Patients’ Time

Health Care Providers Must Stop Wasting Patients’ Time | Pharma & Medical Devices | Scoop.it
An example from Kaiser Permanente shows how to do it.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Study: One-third of docs trust pharma content on HCP sites

Study: One-third of docs trust pharma content on HCP sites | Pharma & Medical Devices | Scoop.it
In general, physicians believe that information provided by pharma companies is difficult to find and lacking in science.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

The Hidden Monopolies That Raise Drug Prices

The Hidden Monopolies That Raise Drug Prices | Pharma & Medical Devices | Scoop.it
How pharmacy benefit managers morphed from processors to predators
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Big Pharma Losing Leverage as Payers Raise Pressure on Price

The world’s biggest drugmakers don’t have the muscle they used to have.
more...
No comment yet.
Scooped by Richard Meyer
Scoop.it!

Widespread Hype Gives False Hope To Many Cancer Patients

Widespread Hype Gives False Hope To Many Cancer Patients | Pharma & Medical Devices | Scoop.it
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
more...
No comment yet.